i
Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
-
11/15/2019
Source: IDSA Practice Guidelines -
Personal Author:
-
Corporate Authors:
-
Description:The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on treatment of multidrug-resistant TB (MDR-TB), as well as isoniazid-resistant but rifampin-susceptible TB.
-
Subject:
-
Source:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
-
No Additional Files
Details:
Supporting Files
More +